Session

Overview: This session will explore strategies to optimise treatment for early breast cancer, pushing the boundaries of current practices. It will highlight how advanced radiotherapy techniques are reducing cardiac risk, improving patient care, and minimising side effects. The use of biomarkers will be discussed, focusing on their potential to personalise treatment and enhance patient outcomes. The session will also review the role of tumour-bed boost, exploring how to identify patients who will benefit most and when it can be safely omitted. Finally, this session will explore the emerging role of artificial intelligence in treatment planning and delivery for early breast cancer.